What are the Historical Developments and Current Growth Metrics of the In-Vitro Transcription Templates Market?
The in-vitro transcription templates market has seen considerable growth due to a variety of factors.
• The in-vitro transcription templates market has grown rapidly in recent years. It will increase from $1.01 billion in 2024 to $1.25 billion in 2025, reflecting a CAGR of 23.7%.
This growth can be attributed to the rising incidence of chronic diseases, increased investment in healthcare and pharmaceutical R&D, improvements in gene therapy technologies, collaborations and partnerships, and advancements in gene therapy.
What Does Future Hold for The In-Vitro Transcription Templates Market By 2029?
The in-vitro transcription templates market is expected to maintain its strong growth trajectory in upcoming years.
• The in-vitro transcription templates market is expected to grow rapidly, reaching $2.9 billion by 2029, with a CAGR of 23.4%.
The growth is fueled by advancements in biotechnology, an increase in R&D activities, greater use of in-vitro transcription templates, demand for early disease diagnosis, and a rising need for mRNA vaccines. Key trends include developments in RNA synthesis technologies, advancements in biotechnology, enzymatic synthesis, and the integration of automation and digitalization.
What Are The Primary Growth Drivers In The In-Vitro Transcription Templates Market?
The increasing focus on gene therapy is expected to drive the growth of the in-vitro transcription templates market. Gene therapy aims to treat genetic diseases by modifying genes, with advances in technologies like CRISPR boosting its potential. In-vitro transcription templates are essential for creating RNA molecules used in gene therapies. In March 2024, the FDA estimated 36 gene therapies had been approved, with more expected to follow, signaling a growing market for related technologies.
What Is The Segmentation Of The Global In-Vitro Transcription Templates Market?
The in-vitro transcription templates market covered in this report is segmented –
1) By Treatment: Vaccine, Therapeutic
2) By Research Stage: Exploratory, Clinical
3) By Disease: Cancer, Infectious Disease, Lifestyle Disease, Genetic Disease, Other Diseases
4) By End User: Pharmaceutical And Biotechnology Companies, Contract Research Organizations (CROs) And Contract Manufacturing Organizations (CMOs), Academics And Research, Other End Users
Subsegments:
1) By Vaccine: MRNA Vaccines, DNA Vaccines
2) By Therapeutic: Gene Therapy, RNA-Based Therapeutics
Pre-Book The In-Vitro Transcription Templates Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
How Are New Trends Impacting The Size Of The In-Vitro Transcription Templates Market?
Leading corporations in the in-vitro transcription templates market are focusing on the development of self-amplifying RNA synthesis facilities to increase the potency and productivity of RNA-based treatments, bringing down manufacturing expenses, and bettering patient results in diverse therapeutic areas. This innovative service enables the creation of self-replicating RNA within host cells, which in turn boosts protein expression from minimal RNA input, thus optimizing the efficiency and efficacy of RNA-based therapies. An illustration of this expansion would be GenScript Biotech Corporation, a biotech firm based in the US, introducing a self-amplifying RNA (saRNA) synthesis service in May 2024. This further broadened its in-vitro transcription RNA synthesis collection. This innovative service boosts the potency and effectiveness of vaccines, immunotherapies, and gene therapies by stimulating robust protein expression from a small RNA amount. The saRNA platform shows potential in reducing dosages, diminishing production expenses, and enhancing patient results. With the backing of comprehensive research and development, GenScript's saRNA showcases high purity and amplified protein expression, ensuring dependable performance.
Who Are the Key Players In The In-Vitro Transcription Templates Market?
Major companies operating in the in-vitro transcription templates market are:
• Thermo Fisher Scientific Inc.
• Danaher Corporation
• Merck KGaA
• Eurofins Genomics LLC
• Agilent Technologies Inc.
• Illumina Inc.
• Bio-Rad Laboratories Inc.
• Qiagen N.V.
• Integrated DNA Technologies Inc.
• Promega Corporation
• Genescript Biotech Corporation
• Takara Bio Inc.
• New England Biolabs
• OriGene Technologies Inc.
• Cayman Chemical
• Synthego Corporation
• Synbio Technologies
• Creative Diagnostics
• VectorBuilder Inc.
• Bio-Synthesis Inc.
• TriLink BioTechnologies
• Norgen Biotek Corporation
• Genaxxon BioScience GmbH
• Enzo Life Sciences Inc.
• GeneCopoeia
What Are The Regional Insights Into The In-Vitro Transcription Templates Market?
North America was the largest region in the in-vitro transcription templates market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the in-vitro transcription templates market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
